Affordable Access

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

Authors
Type
Published Article
Journal
Blood
Publication Date
Volume
106
Issue
2
Pages
458–463
Identifiers
PMID: 15817679
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments